SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-070444
Filing Date
2023-06-12
Accepted
2023-06-12 17:19:27
Documents
15
Period of Report
2023-06-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2318372d1_8k.htm   iXBRL 8-K 40224
2 EXHIBIT 5.1 tm2318372d1_ex5-1.htm EX-5.1 13627
3 EXHIBIT 99.1 tm2318372d1_ex99-1.htm EX-99.1 20619
7 GRAPHIC tm2318372d1_ex99-1img001.jpg GRAPHIC 3358
  Complete submission text file 0001104659-23-070444.txt   269362

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aytu-20230608.xsd EX-101.SCH 3030
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20230608_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20230608_pre.xml EX-101.PRE 22593
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2318372d1_8k_htm.xml XML 3607
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 231009358
SIC: 2834 Pharmaceutical Preparations